Literature DB >> 10852791

Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine.

E M Karjalainen1, A Laitinen, M Sue-Chu, A Altraja, L Bjermer, L A Laitinen.   

Abstract

Asthma-like symptoms, methacholine hyperresponsiveness, and use of asthma medication are prevalent in elite cross-country skiers. We quantitated mucosal inflammatory cell infiltration and tenascin expression in the subepithelial basement membrane in endobronchial biopsy specimens of the proximal airways from 40 elite, competitive skiers (mean: 17.5; range: 16 to 20 yr) without a diagnosis of asthma, in 12 subjects with mild asthma, and in 12 healthy controls, through immunohistochemistry and indirect immunofluorescence, respectively. All of the subjects were nonsmokers. T-lymphocyte, macrophage, and eosinophil counts were, respectively, greater by 43-fold (p < 0.001), 26-fold (p < 0.001), and twofold (p < 0.001) in skiers, and by 70-fold (p < 0.001), 63-fold (p < 0.001), and eightfold (p < 0.001) in asthmatic subjects than in controls. In skiers, neutrophil counts were more than twofold greater than in asthmatic subjects, and mast cell counts were not significantly different than in controls. Tenascin expression (as measured through the thickness of the tenascin-specific immunoreactivity band in the basement membrane) was increased in skiers (median: 6.7 microm; interquartile range [IQR]: 5.3 to 8.5 microm, p < 0.001) and asthmatic subjects (mean: 8.8 microm; IQR: 7.2 to 10.8 microm, p < 0. 001) compared with controls (mean: 0.8 microm; IQR: 0 to 3.1 microm) and did not correlate with inflammatory cell counts. Inflammatory changes were present irrespective of asthmalike symptoms, hyperresponsiveness, or atopy. Prolonged repeated exposure of the airways to inadequately conditioned air may induce inflammation and remodeling in competitive skiers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852791     DOI: 10.1164/ajrccm.161.6.9907025

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  60 in total

Review 1.  Exercise-induced bronchospasm in the elite athlete.

Authors:  Kenneth W Rundell; David M Jenkinson
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 2.  Variability of inflammatory cell counts on bronchial biopsies of normal subjects.

Authors:  H Turcotte; M Laviolette; M Boutet; L-P Boulet
Journal:  Lung       Date:  2003       Impact factor: 2.584

Review 3.  Exercise-induced bronchoconstriction.

Authors:  Robert W Gotshall
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Non-sensitising air pollution at workplaces and adult onset asthma.

Authors:  U Flodin; P Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2003-09-23       Impact factor: 3.015

5.  Airway immunopathology of asthma with exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; Mark W Moody; Moira L Aitken; William R Henderson
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

6.  Screening for exercise-induced bronchoconstriction in college athletes.

Authors:  Jonathan P Parsons; David Cosmar; Gary Phillips; Christopher Kaeding; Thomas M Best; John G Mastronarde
Journal:  J Asthma       Date:  2012-01-25       Impact factor: 2.515

7.  Mechanical impedance of the respiratory tract in divers before and after simulated deep dives.

Authors:  Birger Neubauer; Till S Mutzbauer; Niklas Struck; Hans-Jürgen Smith; Kay Tetzlaff
Journal:  Eur J Appl Physiol       Date:  2005-09-17       Impact factor: 3.078

8.  Is the healthy respiratory system (always) built for exercise?

Authors:  Jerome A Dempsey
Journal:  J Physiol       Date:  2006-07-27       Impact factor: 5.182

Review 9.  Asthma, outdoor air quality and the Olympic Games.

Authors:  Donald C McKenzie; Louis-Philippe Boulet
Journal:  CMAJ       Date:  2008-08-07       Impact factor: 8.262

Review 10.  Asthma phenotypes: the evolution from clinical to molecular approaches.

Authors:  Sally E Wenzel
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.